Dongsheng Ouyang

2.3k total citations
78 papers, 1.8k citations indexed

About

Dongsheng Ouyang is a scholar working on Pharmacology, Molecular Biology and Pharmacology. According to data from OpenAlex, Dongsheng Ouyang has authored 78 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Pharmacology, 25 papers in Molecular Biology and 16 papers in Pharmacology. Recurrent topics in Dongsheng Ouyang's work include Pharmacogenetics and Drug Metabolism (21 papers), Pharmacological Effects of Natural Compounds (9 papers) and Ginseng Biological Effects and Applications (8 papers). Dongsheng Ouyang is often cited by papers focused on Pharmacogenetics and Drug Metabolism (21 papers), Pharmacological Effects of Natural Compounds (9 papers) and Ginseng Biological Effects and Applications (8 papers). Dongsheng Ouyang collaborates with scholars based in China, United States and South Korea. Dongsheng Ouyang's co-authors include Guoping Yang, Zhi‐Rong Tan, Yong‐Yu Yang, Xi‐Ding Yang, Xiangchang Zeng, Zhaoqian Liu, Yao Chen, Lulu Chen, Song‐Lin Huang and Xiaoping Chen and has published in prestigious journals such as PLoS ONE, Applied Microbiology and Biotechnology and Journal of Ethnopharmacology.

In The Last Decade

Dongsheng Ouyang

75 papers receiving 1.7k citations

Peers

Dongsheng Ouyang
Wonku Kang South Korea
Dongsheng Ouyang
Citations per year, relative to Dongsheng Ouyang Dongsheng Ouyang (= 1×) peers Wonku Kang

Countries citing papers authored by Dongsheng Ouyang

Since Specialization
Citations

This map shows the geographic impact of Dongsheng Ouyang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dongsheng Ouyang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dongsheng Ouyang more than expected).

Fields of papers citing papers by Dongsheng Ouyang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dongsheng Ouyang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dongsheng Ouyang. The network helps show where Dongsheng Ouyang may publish in the future.

Co-authorship network of co-authors of Dongsheng Ouyang

This figure shows the co-authorship network connecting the top 25 collaborators of Dongsheng Ouyang. A scholar is included among the top collaborators of Dongsheng Ouyang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dongsheng Ouyang. Dongsheng Ouyang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Xin, Lulu Chen, Xintong Wang, et al.. (2025). Parametric Population Pharmacokinetics Model Repository of Rifampicin: Model-Informed Individualized Therapy. Clinical Pharmacology Advances and Applications. Volume 17. 49–78. 1 indexed citations
2.
Wang, Jianmin, Zixu Wang, Wei Long, et al.. (2024). Diffusion-based generative drug-like molecular editing with chemical natural language. Journal of Pharmaceutical Analysis. 15(6). 101137–101137. 4 indexed citations
3.
Li, Chao, Chaopeng Li, Xiaohui Li, et al.. (2021). CYP2C19 Genotyping May Provide a Better Treatment Strategy when Administering Escitalopram in Chinese Population. Frontiers in Pharmacology. 12. 730461–730461. 9 indexed citations
4.
Fang, Qing, Na Liu, Jinfeng Liu, et al.. (2021). Trimethylamine N-Oxide Exacerbates Renal Inflammation and Fibrosis in Rats With Diabetic Kidney Disease. Frontiers in Physiology. 12. 682482–682482. 86 indexed citations
5.
Huang, Qi, Fengyu Zhang, Shao Liu, Yueping Jiang, & Dongsheng Ouyang. (2021). Systematic investigation of the pharmacological mechanism for renal protection by the leaves of Eucommia ulmoides Oliver using UPLC-Q-TOF/MS combined with network pharmacology analysis. Biomedicine & Pharmacotherapy. 140. 111735–111735. 33 indexed citations
6.
Fang, Qing, et al.. (2021). Roles of Gut Microbial Metabolites in Diabetic Kidney Disease. Frontiers in Endocrinology. 12. 636175–636175. 49 indexed citations
7.
Rao, Tai, Zhi‐Rong Tan, Jingbo Peng, et al.. (2019). The pharmacogenetics of natural products: A pharmacokinetic and pharmacodynamic perspective. Pharmacological Research. 146. 104283–104283. 75 indexed citations
8.
Chen, Lulu, Luping Zhou, Jie Huang, et al.. (2018). Single- and Multiple-Dose Trials to Determine the Pharmacokinetics, Safety, Tolerability, and Sex Effect of Oral Ginsenoside Compound K in Healthy Chinese Volunteers. Frontiers in Pharmacology. 8. 965–965. 56 indexed citations
9.
Luo, Wei, et al.. (2016). Advance of Eucommia ulmoides Oliver. for anti-osteoporosis. 21(12). 1440. 2 indexed citations
10.
Yang, Xi‐Ding, Yong‐Yu Yang, Dongsheng Ouyang, & Guoping Yang. (2014). A review of biotransformation and pharmacology of ginsenoside compound K. Fitoterapia. 100. 208–220. 218 indexed citations
11.
Huang, Xi, Ying Guo, Weihua Huang, et al.. (2014). Searching the Cytochrome P450 Enzymes for the Metabolism of Meranzin Hydrate: A Prospective Antidepressant Originating from Chaihu-Shugan-San. PLoS ONE. 9(11). e113819–e113819. 14 indexed citations
12.
He, Xiaoyun, et al.. (2012). Effects of curcumin on the pharmacokinetics of talinolol in human withABCB1polymorphism. Xenobiotica. 42(12). 1248–1254. 15 indexed citations
13.
Gu, Juan, Junjie Wang, Yan Jin, et al.. (2010). Effects of lignans extracted from Eucommia ulmoides and aldose reductase inhibitor epalrestat on hypertensive vascular remodeling. Journal of Ethnopharmacology. 133(1). 6–13. 39 indexed citations
14.
Ouyang, Dongsheng. (2007). Aldose reductase:a novel target for cardioprotective intervention after myocardial ischemia. 1 indexed citations
15.
Cao, Wei, Yajie Cao, Zeneng Cheng, et al.. (2007). Effect of sinomenine on human cytochrome P450 activity. Clinica Chimica Acta. 379(1-2). 113–118. 18 indexed citations
16.
Ouyang, Dongsheng. (2006). Progresses in the Pharmacology of Chlorogenic Acid. Tianran chanwu yanjiu yu kaifa. 7 indexed citations
17.
Liu, Yali, Wei Zhang, Zhi‐Rong Tan, et al.. (2005). Effect of the CYP2C9*3 allele on lornoxicam metabolism. Clinica Chimica Acta. 364(1-2). 287–291. 15 indexed citations
18.
Huang, Ping, Bing Zhu, Liansheng Wang, et al.. (2003). Relationship between CYP3A activity and breast cancer susceptibility in Chinese Han women. European Journal of Clinical Pharmacology. 59(5-6). 471–476. 10 indexed citations
19.
Yu, Bangning, Guo‐Lin Chen, Nan He, et al.. (2003). PHARMACOKINETICS OF CITALOPRAM IN RELATION TO GENETIC POLYMORPHISM OF CYP2C19. Drug Metabolism and Disposition. 31(10). 1255–1259. 70 indexed citations
20.
Cheng, Zeneng, Yan Shu, Zhaoqian Liu, et al.. (2001). Role of cytochrome P450 in estradiol metabolism in vitro.. PubMed. 22(2). 148–54. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026